Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 83.58
+13.93 (20.00%)
At close: Aug 4, 2026
Sino Biological,Inc. Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 727.69 | 699.56 | 613.67 | 646.39 | 574.6 | 965.27 |
Revenue Growth | 18.01% | 14.00% | -5.06% | 12.49% | -40.47% | -39.53% |
Gross Profit Gross Profit Growth | 532.39 | 509.09 | 442.69 | 520.54 | 479.59 | 896.29 |
Operating Income Operating Income Growth | 109.5 | 90.21 | 29.29 | 135.76 | 203.53 | 696.56 |
Net Income Net Income Growth | 157.25 | 147.74 | 121.93 | 260.13 | 302.96 | 720.01 |
Earnings Per Share EPS Growth | 1.29 | 1.21 | 0.95 | 2.01 | 2.66 | 6.69 |
EPS Growth | 61.67% | 27.45% | -52.67% | -24.30% | -60.22% | -42.53% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
China China Growth | 321.07 | 259.31 | 245.27 | 224.97 |
Overseas Overseas Growth | 378.5 | 354.36 | 401.11 | 349.63 |
Total Total Growth | 699.56 | 613.67 | 646.39 | 574.6 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 3,255 | 3,222 | 3,949 | 4,849 | 5,802 | 6,511 |
Total Debt Total Debt Growth | 46.53 | 53.52 | 67.37 | 85.06 | 70.46 | 47.36 |
Net Cash (Debt) Net Cash Growth | 3,209 | 3,169 | 3,882 | 4,764 | 5,732 | 6,463 |
Net Cash Growth | -17.68% | -18.38% | -18.51% | -16.89% | -11.32% | 472.58% |
Net Cash Per Share Net Cash Per Share Growth | 26.38 | 26.05 | 30.34 | 36.87 | 50.32 | 60.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 176.81 | 146.19 | 113.73 | 322.56 | 249.39 | 642.62 |
Capital Expenditures CapEx Growth | -115.44 | -101.05 | -69.95 | -1,043 | -156.06 | -47.9 |
Free Cash Flow Free Cash Flow Growth | 61.38 | 45.14 | 43.78 | -720.8 | 93.34 | 594.72 |
Free Cash Flow Growth | 31.46% | 3.10% | - | - | -84.31% | -44.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 73.16% | 72.77% | 72.14% | 80.53% | 83.47% | 92.85% |
Operating Margin | 15.05% | 12.90% | 4.77% | 21.00% | 35.42% | 72.16% |
Pretax Margin | 27.55% | 25.66% | 23.03% | 44.55% | 59.61% | 87.59% |
Profit Margin | 21.61% | 21.12% | 19.87% | 40.24% | 52.73% | 74.59% |
FCF Margin | 8.43% | 6.45% | 7.13% | -111.51% | 16.24% | 61.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 5.200 | 5.200 | 1.000 | 2.000 | 2.000 | 5.263 |
Dividend Per Share Growth | 420.00% | 420.00% | -50.00% | 0% | -62.00% | - |
Dividend Yield | 7.47% | 7.83% | 1.76% | 2.71% | 2.29% | 3.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 64.65 | 55.66 | 61.70 | 40.93 | 42.50 | 32.65 |
Forward PE | - | 52.81 | 42.22 | 34.41 | 38.78 | 20.76 |
P/FCF Ratio | 165.64 | 182.15 | 171.82 | - | 137.95 | 39.53 |
PS Ratio | 13.97 | 11.75 | 12.26 | 16.47 | 22.41 | 24.35 |